DexCom Non-GAAP EPS of $0.68 misses by $0.17, revenue of $698.2M in-line
DexCom press release (NASDAQ:DXCM): Q4 Non-GAAP EPS of $0.68  misses by $0.17.
Revenue of $698.2M (+22.7% Y/Y) in-line.
U.S. revenue growth of 15% and international revenue growth of 54% on a reported basis. International revenue growth was 41% on an organic basis.
FY22 Guidance: 
Revenue of approximately $2.82 - 2.94 billion vs. $2.97B consensus, (15-20% growth)
Non-GAAP Gross Profit Margin of approximately 65%
Non-GAAP Operating Margin of approximately 16%
Adjusted EBITDA Margin of approximately 25%